|
Volumn 30, Issue 3, 1998, Pages 204-205
|
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PROSTATE SPECIFIC ANTIGEN;
TUMOR MARKER;
ADJUVANT THERAPY;
ADULT;
AGED;
ARTICLE;
BLOOD;
BRACHYTHERAPY;
HUMAN;
MALE;
MIDDLE AGED;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
PROSTATE TUMOR;
PROSTATECTOMY;
RISK;
SURVIVAL RATE;
ADULT;
AGED;
BRACHYTHERAPY;
COMBINED MODALITY THERAPY;
HUMANS;
MALE;
MIDDLE AGED;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATECTOMY;
PROSTATIC NEOPLASMS;
RADIOTHERAPY, ADJUVANT;
RISK;
SURVIVAL RATE;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 0032234140
PISSN: 07436661
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (0)
|